Normal
23rd -24th June 2022

3rd Annual MarketsandMarkets Single-Cell Analysis Conference

Hyatt Regency Boston/Cambridge

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

Our 3rd Annual MarketsandMarkets Single-Cell Analysis Conference scheduled to be held on 23rd and 24th June 2022 in Hyatt Regency Boston/Cambridge  aims to bring together the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe to address the recent developments and challenges in analyzing single cell and also provides the platform to share the knowledge with academic peers and present their research papers and reports.

 

Co-Related Conferences
WHAT TO EXPECT

Key Highlights

  • Integrating Bulk- Single Cell and Spatial Transcriptomics towards integrative disease understanding
  • ScRNA-Seq Data for Single-Cell Analysis
  • Multi-Omics of Single Cells: Strategies and Applications
  • Single-Cell Genome-Wide Bisulfite Sequencing
  • Single-Cell Analysis in Cancer Genomics
  • Nanopore Technology – A Potential Application in Functional Genomics  
  • Algorithmic advances in Machine Learning & Artificial Intelligence for single cell expression analysis
  • Current Methodologies and Challenges of Single-Cell and Single-Nucleus RNA-Sequencing

Why Attend?

  • Learn about the Single- Cell Biology and its applications
  • Meet global leaders and researchers from the industry and Academics
  • 100+ Professional attending from all around the globe
  • Access to online presentations on-demand post-summit
  • Case studies presented from leading technology collaborations 
  • Interactive panel discussions
  • Futuristic Agenda
  • Program address the recent challenges in the field of research

Who Should Attend?

Professionals in Healthcare, Therapeutics, Universities/Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers
  • Postdocs
  • Senior Scientists
  • Senior Researchers
  • Professors
  • Bioinformatician
  • Computational Biologist

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairman

08:55 - 09:00
Overview of Developments in Single-Cell Technology

Keynote Presentation - The evolving role of Integrating Bulk- Single Cell and Spatial Transcriptomics towards integrative disease understanding

09:00 - 09:30 Arvind Rao, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan

Leveraging single cell technologies to uncover key regulators of (multi)cellular processes: Applications to tumor immunology

09:30 - 10:00 Livnat Jerby, Assistant Professor of Genetics, Stanford University

Meet 10X single cell RNA sequencing from Novogene

10:00 - 10:30 Eric Iverson, Technical Support Supervisor, Novogene Corporation Inc.

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Distinguishing cancer cells from normal cells in single-cell RNA sequencing data sets

11:15 - 11:45 Alexandre Alloy, Scientist - Computational Biology, Bristol Myers Squibb

Detect of the undetectable unconventional circulating neoplastic cells: Pancreatic Ductal Adenocarcinoma detection from liquid biopsy samples

11:45 - 12:15 Yu-Jui Chiu, Associate Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Sequencing Technologies and its Applications in Single-Cell Analysis

Recent advances in spatial and single-cell proteome profiling

12:15 - 12:45 Yiran Liang, Research Associate, Dr. Ryan Kelly’s lab - Department of Chemistry and Biochemistry - Brigham Young University

Combining sequence and structure information from DNA (genomics), RNA (Coding and Noncoding), and proteins, to better understand genome organization and function

12:45 - 13:15 Miten Jain, Assistant Research Scientist, University of California Santa Cruz

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Evaluating Neoantigen Immunotherapies in the Clinic

14:15 - 14:45 Matt Davis, Director, Molecular biology and Sequencing, Gritstone Oncology, Inc.

Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry

14:45 - 15:15 Jessica McDonough, Co-Founder, Attivare Therapeutics

Single Cell Analysis for Cell-Based Therapies

15:15 - 15:45 Anka G. Ehrhardt, Director, Cell-Based Sciences, AR&D, Merck
Diving into Multi-Omics Single-Cell Analysis

Bulk and scRNA-seq analysis of the developing vertebrate retina reveals complex epigenetic regulation of the CTBP2/RIBEYE locus.

16:30 - 17:00 Ray Enke, Associate Professor of Biology, James Madison University
Prioritizing the Next-Gen Technologies in the Universe of Single-Cell Analysis

Breakout Session: State-of-the art and future of Single-cell technologies

17:00 - 17:30 Ajay Nair, Associate Research Scientist, Columbia University in the City of New York

End of Day 1 followed by Drinks Reception and Networking

17:35 - 17:35

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55
Tailoring Models and Therapies under Single Cell Analysis

Opening Remarks from the Chairman

08:55 - 09:00

Keynote Presentation- Identifying Master Regulators Causing Diseases Using Single-Cell Analysis

09:00 - 09:30 Ajay Nair, Associate Research Scientist, Columbia University in the City of New York

Single Cell Mass Cytometry and AI-Guided Analysis to Predict Therapeutic Response and Monitor and Direct Clinical Trials

09:30 - 10:00

Elucidating the cellular states of CD8+ T cells regulating anti-PD1 response using multi-omics single cell sequencing

10:00 - 10:30 Namit Kumar, Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:00

Single-Cell Functional Proteomics by Cyclic MIST Chip for Human Disease Study

11:15 - 11:45 Jun Wang, Associate Professor, Stony Brook University

Single Cell Gene Regulatory Network Perturbations in Disease

11:45 - 12:15 S. Stephen Yi, University of Texas at Austin, Director of Bioinformatics, Faculty of Biomedical Engineering and Oncology

Breakout Session by- Why Single-Cell Analysis and How?

12:15 - 12:45 Namit Kumar, Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb
Shaping the Single-Cell Medicine Era with Multi-Model Analysis

Multiplexed Image Platforms for Cancer Immunoprofiling and Biomarker Discovery

12:45 - 13:15 Edwin Roger Parra Cuentas, Director of the Multiplex Immunoflouresence and Image Analysis Laboratory, The University of Texas MD Anderson Cancer

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

End of Conference

14:15 - 14:15

Closing Remarks from the Chairman

15:45 - 15:50

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meeting

15:50 - 16:50
CONFERENCE SPEAKERS
Advisors
Yuhwa Lo
Yuhwa Lo
Professor, Electrical & Computer Engineering, University of California, San Diego
Arvind Rao
Arvind Rao
Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan
Alexandre Alloy
Alexandre Alloy
Scientist - Computational Biology, Bristol Myers Squibb
Joshua Campbell
Joshua Campbell
Professor, Boston University School of Medicine
Speakers
Edwin Roger Parra Cuentas
Edwin Roger Parra Cuentas
Director of the Multiplex Immunoflouresence and Image Analysis Laboratory, The University of Texas MD Anderson Cancer
Yiran Liang
Yiran Liang
Research Associate, Dr. Ryan Kelly’s lab - Department of Chemistry and Biochemistry - Brigham Young University
S. Stephen Yi
S. Stephen Yi
University of Texas at Austin, Director of Bioinformatics, Faculty of Biomedical Engineering and Oncology
Jessica McDonough
Jessica McDonough
Co-Founder, Attivare Therapeutics
Yu-Jui Chiu
Yu-Jui Chiu
Associate Scientist, CEDAR, OHSU Knight Cancer Institute, School of Medicine
Miten Jain
Miten Jain
Assistant Research Scientist, University of California Santa Cruz
Eric Iverson
Eric Iverson
Technical Support Supervisor, Novogene Corporation Inc.
Namit Kumar
Namit Kumar
Principal Scientist - Early Development Predictive Sciences, Bristol Myers Squibb
SPONSORS
Gold
example-image

Proteome Sciences

Silver
example-image

Novogene

Visiting Partners
example-image

AmericanBio

Exhibition Partner
example-image

PerkinElmer

Meeting Partner
example-image

Mission Bio

PARTNERS
Supporting Association
ASEBio

ASEBio

LOCATION
Hyatt Regency Boston/Cambridge
About the Hotel

PAST EVENT GALLERY
  • Networking-Room
  • Networking-Event
  • Networking-Exhibition-Audience
  • Networking-Exhibition
  • Discussion-Conference-Audience
  • Conference-Speaker
  • Conference-Audience-Discussion
  • Conference-Room-Audience
  • Conference-Room
  • Conference-Audience
  • High Potent Medicines Conference - Networking area
  • High Potent Medicines Conference - Exhibition Area - Booths